Development of a dietary formulation of the SHetA2 chemoprevention drug for mice

Development of cancer chemoprevention compounds requires enhanced consideration for toxicity and route of administration because the target population is healthy. The small molecule drug, SHetA2 (NSC 726189), exhibited in vivo chemoprevention activity and lack of toxicity when administered by oral g...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Invest New Drugs
Main Authors: Benbrook, Doris M., Janakiram, Naveena B., Chandra, Vishal, Pathuri, Gopal, Madka, Venkateshwar, Stratton, Nicole C., Masamha, Chioniso P., Farnsworth, Cassadie N., Garcia-Contreras, Lucila, Hatipoglu, Manolya Kukut, Lighfoot, Stan, Rao, Chinthalapally V.
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2017
Assuntos:
Preclinical Studies
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014882/
https://ncbi.nlm.nih.gov/pubmed/29273857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-017-0550-0
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares